You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

MabCampath

Showing 1 - 25 of 32
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

T-cell-prolymphocytic Leukemia Trial in Cologne (Fludarabine, Mitoxantrone, Cyclophosphamide and Alemtuzumab, Alemtuzumab)

Completed
  • T-cell-prolymphocytic Leukemia
  • Fludarabine, Mitoxantrone, Cyclophosphamide and Alemtuzumab
  • Alemtuzumab
  • Cologne, Germany
    University Hospital Cologne
Dec 16, 2021

Sickle Cell Disease Trial in Chicago (Allogeneic Non-Myeloablative Stem Cell Transplantation, Alemtuzumab, Sirolimus)

Recruiting
  • Sickle Cell Disease
  • Allogeneic Non-Myeloablative Stem Cell Transplantation
  • +2 more
  • Chicago, Illinois
    University of Illinois at Chicago
Feb 16, 2022

Sickle Cell Disease Trial in Duarte (drug, procedure, radiation)

Recruiting
  • Sickle Cell Disease
  • Duarte, California
    City of Hope Comprehensive Cancer Center
Jul 31, 2022

Immunodeficiency Syndrome, Non-Cancer Diagnosis Trial in United States (biological, procedure, drug, other, radiation)

Completed
Has Results
  • Immunodeficiency Syndrome
  • Non-Cancer Diagnosis
  • Alemtuzumab
  • +7 more
  • Oakland, California
  • +5 more
Feb 5, 2020

Chronic Lymphocytic Leukemia Trial in Germany (Alemtuzumab i.v., Alemtuzumab s.c.)

Completed
  • Chronic Lymphocytic Leukemia
  • Alemtuzumab i.v.
  • Alemtuzumab s.c.
  • Cologne, Germany
  • +5 more
Jun 12, 2019

Lymphoma Trial in Chicago (alemtuzumab)

Completed
  • Lymphoma
  • alemtuzumab
  • Chicago, Illinois
  • +1 more
Feb 5, 2019

Acute Lymphoblastic Leukemia, Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 Trial in United States

Completed
Has Results
  • Acute Lymphoblastic Leukemia
  • Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
  • Alemtuzumab
  • +20 more
  • Palo Alto, California
  • +100 more
Aug 3, 2022

Relapsing Remitting Multiple Sclerosis Trial in Vancouver (MabCampath-1h)

Completed
  • Relapsing Remitting Multiple Sclerosis
  • Vancouver, British Columbia, Canada
    University of British Columbia Hospital
Oct 12, 2018

Lymphoma, T-Cell, Peripheral Trial in Worldwide (CHOP14 chemo (cyclophosphamide, hydroxydaunorubicin, vincristin, prednison)

Completed
  • Lymphoma, T-Cell, Peripheral
  • CHOP14 chemotherapy (cyclophosphamide, hydroxydaunorubicin, vincristin, prednison) plus G-CSF, combined with alemtuzumab
  • CHOP14 chemotherapy (see specification under Arm B) plus G-CSF
  • Linz, Austria
  • +58 more
Feb 27, 2019

B-cell Chronic Lymphocytic Leukemia Trial in Austria (Fludarabine phosphate, Alemtuzumab)

Completed
  • B-cell Chronic Lymphocytic Leukemia
  • Feldkirch, Austria
  • +7 more
Dec 6, 2017

B Cell Chronic Lymphocytic Leukemia Trial in United States (alemtuzumab)

Completed
  • B Cell Chronic Lymphocytic Leukemia
  • Tucson, Arizona
  • +19 more
Jul 27, 2016

Kidney Transplantation Trial (MabCampath,, Remicade, Sirolimus)

Completed
  • Kidney Transplantation
  • (no location specified)
Mar 12, 2016

Hematologic Tumors, Anemia, Aplastic, Hemoglobinuria, Paroxysmal Trial in Tucson (haploidentical allogeneic PBSC transp)

Completed
  • Hematologic Neoplasms
  • +3 more
  • haploidentical allogeneic PBSC transp
  • Tucson, Arizona
    Arizona Cancer Center/University Medical Center
Mar 1, 2016

Kidney Transplant Failure and Rejection Trial in Chicago (Tacrolimus (TAC), Sirolimus, Alemtuzumab)

Terminated
Has Results
  • Kidney Transplant Failure and Rejection
  • Tacrolimus (TAC)
  • +3 more
  • Chicago, Illinois
    Northwestern University/Northwestern Memorial Hospital
Oct 20, 2015

Leukemia, Lymphocytic, Chronic, B-Cell Trial in Japan (alemtuzumab)

Completed
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • Nagoya, Aichi, Japan
  • +5 more
Apr 29, 2015

GVHD Trial in Spain (Alemtuzumab)

Terminated
  • Graft Versus Host Disease
  • Badalona, Barcelona, Spain
  • +9 more
Feb 3, 2015

Leukemia, B-cell Leukemia, Chronic Leukemia Trial in Stanford (Alemtuzumab, Fludarabine, Cytoxan)

Completed
Has Results
  • Leukemia
  • +3 more
  • Stanford, California
    Stanford University School of Medicine
Sep 25, 2014

B-Cell Chronic Lymphocytic Leukemia (B-CLL) Trial in Worldwide (Alemtuzumab)

Completed
Has Results
  • B-Cell Chronic Lymphocytic Leukemia (B-CLL)
  • Alemtuzumab
  • La Jolla, California
  • +20 more
Feb 10, 2014

Non-Hodgkins Lymphoma Trial in United States (alemtuzumab)

Terminated
  • Non-Hodgkins Lymphoma
  • Aurora, Colorado
  • +16 more
Mar 4, 2015

Patient Acceptance of Treatment With MabCampath in Chronic

Terminated
  • Chronic Lymphocytic Leukemia
  • Alemtuzumab (MabCampath)
  • Many Locations, Bosnia and Herzegovina
  • +2 more
Dec 2, 2013

Aplastic Anemia Trial in Monterrey (Alemtuzumab and Rituximab)

Withdrawn
  • Aplastic Anemia
  • Alemtuzumab and Rituximab
  • Monterrey, Nuevo Leon, Mexico
    Hospital Universitario, Dr. Jose E. Gonzalez
Jan 3, 2014

Quality of Life in Patients Under Treatment for B-Chronic

Completed
  • Leukemia, B-Cell, Chronic
  • Alemtuzumab (MabCampath, BAY86-5045) and Fludarabine Phosphate (Fludara, BAY86-4864)
  • Many locations, Italy
    (unnamed)
Dec 2, 2013

B-Cell Chronic Lymphocytic Leukemia Trial in Worldwide (FluCAM [Fludara + Campath], fludarabine phosphate)

Completed
Has Results
  • B-Cell Chronic Lymphocytic Leukemia
  • FluCAM [Fludara + Campath]
  • fludarabine phosphate
  • Fort Myers, Florida
  • +47 more
Feb 10, 2014

Leukemia Trial in Rouen (Campath, rituximab, cyclophosphamide)

Completed
  • Leukemia
  • Campath
  • +3 more
  • Rouen, France
    Centre Henri Becquerel
Jul 24, 2013

Peripheral T-Cell Lymphoma Trial (Alemtuzumab)

Completed
  • Peripheral T-Cell Lymphoma
  • (no location specified)
Mar 6, 2013